FinTrust Capital Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-100,780
| Closed | -$230K | – | 1444 |
|
|
2024
Q2 | $230K | Hold |
100,780
| – | – | 0.04% | 271 |
|
|
2024
Q1 | $435K | Hold |
100,780
| – | – | 0.08% | 181 |
|
|
2023
Q4 | $307K | Buy |
100,780
+100,715
| +154,946% | +$307K | 0.06% | 221 |
|
|
2023
Q3 | $94 | Hold |
65
| – | – | ﹤0.01% | 1197 |
|
|
2023
Q2 | $353 | Hold |
65
| – | – | ﹤0.01% | 1145 |
|
|
2023
Q1 | $353 | Hold |
65
| – | – | ﹤0.01% | 1140 |
|
|
2022
Q4 | $353 | Hold |
65
| – | – | ﹤0.01% | 1142 |
|
|
2022
Q3 | $1K | Hold |
65
| – | – | ﹤0.01% | 1205 |
|
|
2022
Q2 | $1K | Hold |
65
| – | – | ﹤0.01% | 1190 |
|
|
2022
Q1 | $0 | Hold |
65
| – | – | ﹤0.01% | 1307 |
|
|
2021
Q4 | $1K | Hold |
65
| – | – | ﹤0.01% | 1160 |
|
|
2021
Q3 | $1K | Hold |
65
| – | – | ﹤0.01% | 1135 |
|
|
2021
Q2 | $1K | Hold |
65
| – | – | ﹤0.01% | 1143 |
|
|
2021
Q1 | $2K | Buy |
+65
| New | +$2K | ﹤0.01% | 1103 |
|